Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other Non-Current Liabilities (2016 - 2025)

Fortress Biotech has reported Other Non-Current Liabilities over the past 13 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $1.4 million for Q4 2025, down 17.6% from a year ago — trailing twelve months through Dec 2025 was $1.4 million (down 17.6% YoY), and the annual figure for FY2025 was $1.4 million, down 17.6%.
  • Other Non-Current Liabilities for Q4 2025 was $1.4 million at Fortress Biotech, down from $1.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for FBIO hit a ceiling of $4.4 million in Q3 2021 and a floor of $362000.0 in Q1 2021.
  • Median Other Non-Current Liabilities over the past 5 years was $1.8 million (2023), compared with a mean of $1.9 million.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 74.71% in 2021 and later skyrocketed 448.62% in 2022.
  • Fortress Biotech's Other Non-Current Liabilities stood at $2.0 million in 2021, then decreased by 9.15% to $1.8 million in 2022, then increased by 2.49% to $1.9 million in 2023, then fell by 7.24% to $1.8 million in 2024, then dropped by 17.6% to $1.4 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $1.4 million (Q4 2025), $1.6 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.